Pacira BioSciences, Inc. PCRX Business Segments — Adjusted cost of goods sold

Similar metrics at other companies

BBWIReportable Segment — Adjusted Cost of Goods Sold

$521M+2.4%

CENXReportable Segment — Cost Of Goods And Services Sold, Adjusted

$537.1M-6.6%

CALXReportable Segment — Cost Of Goods And Services Sold, Adjusted

$119.79M+24.2%

OTEXReportable Segment — Adjusted cost of revenues

$298.99M-2.1%

SYNAReportable Segment — Adjusted cost of revenue

$136.5M+10.1%

YETIReportable Segment — Cost of goods sold

$170.2M+13.9%

Questions, answered.

What is Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold?

Pacira BioSciences, Inc. (PCRX) reported business segments — adjusted cost of goods sold of $34.77M in Q1 2026.

How has Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold changed year-over-year?

Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold increased by 6.7% year-over-year, from $32.59M to $34.77M.

What is the long-term trend for Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold?

Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold has grown at a -7.9% compound annual growth rate (CAGR), from $174.86M to $136.78M.

What does business segments — adjusted cost of goods sold mean?

Reflects the direct costs attributable to the production of goods sold by the segment, adjusted to exclude non-recurring or non-cash items. It is a key indicator of manufacturing efficiency and the direct profitability of the segment's core product offerings.